KZA 0.00% 8.0¢ kazia therapeutics limited

from the 6-23 Edison ReportWhile Kazia has fully funded the...

  1. 25 Posts.
    lightbulb Created with Sketch. 1
    from the 6-23 Edison Report

    While Kazia has fully funded the ongoing Phase IIa study of GDC-0084 in GBM, it would require additional funds of ~A$15–20m for a Phase IIb trial, which could result in significant dilution of existing shareholders.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.